Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis
Arthritis & Rheumatology · 2024-06 · 76 (6) · 845-856
DOI: 10.1002/art.42795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 07.03.2024. Verfasst von Yilong Fang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Medical University and Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid, Dioxygenases, Epigenesis, Genetic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Outstanding Youth of Anhui Province, Research Project of Outstanding Youth of University in Anhui Province, Project of Improvement of Scientific Ability of Anhui Medical University.
Abstract (Originalsprache)
Objective
The specific role of fibroblast‐like synoviocytes (FLSs) in the pathogenesis of rheumatoid arthritis (RA) is still not fully elucidated. This study aimed to explore the molecular mechanisms of epigenetic pathways, including three epigenetic factors, microRNA (miRNA)‐22 (MIR22), ten‐eleven translocation methylcytosine dioxygenase 3 (TET3), and MT‐RNR2 like 2 (MTRNR2L2), in RA‐FLSs.
Methods
The expression of MIR22, TET3, and MTRNR2L2 in the synovium of patients with RA and arthritic mice were determined by fluorescence in situ hybridization, quantitative polymerase chain reaction (qPCR), immunohistochemistry, and Western blot. Mir22 −/− and Tet3 +/− mice were used to establish a collagen antibody–induced arthritis (CAIA) model. Mir22 angomir and Tet3 small interfering RNA (siRNA) were used to illustrate the therapeutic effects on arthritis using a collagen‐induced (CIA) model. Bioinformatics, luciferase reporter assay, 5‐hydroxymethylcytosine (5hmC) dot blotting, chromatin immunoprecipitation–qPCR, and hydroxymethylated DNA immunoprecipitation were conducted to show the direct repression of MIR22 on the TET3 and transcriptional activation of TET3 on MTRNR2L2.
Results
The Mir22 −/− CAIA model and RA‐FLS–related in vitro experiments demonstrated the inhibitory effect of MIR22 on inflammation. MIR22 can directly inhibit the translation of TET3 in RA‐FLSs by binding to its 3′ untranslated region in TET3. The Tet3 +/− mice–established CAIA model showed less severe symptoms of arthritis in vivo. In vitro experiments further confirmed the proinflammatory effect of TET3 in RA. In addition, the CIA model was used to validate the therapeutic effects of Mir22 angomir and Tet3 siRNA. Finally, TET3 exerts its proinflammatory effect by promoting 5hmC production in the promoter of its target MTRNR2L2 in RA‐FLSs.
Conclusion
The key role of the MIR22‐TET3‐MTRNR2L2 pathway in RA‐FLSs provided an experimental basis for further studies into the pathogenesis and related targets of RA from the perspective of FLSs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Anhui Medical University and Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, China.
- The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, China.
- The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Guangzhou National Laboratory, Guangzhou, China.
ORCID-Profile: Yilong Fang, Wei Wei, Jiajie Tu
Förderung
- Natural Science Foundation of Outstanding Youth of Anhui Province
- Research Project of Outstanding Youth of University in Anhui Province
- Project of Improvement of Scientific Ability of Anhui Medical University
- National Natural Science Foundation of China
- Support Program of Outstanding Young Talent in University
- The Open Fund of Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, P.R. China
- Natural Science Foundation of Anhui Province for young scholars
- Anhui Medical University
Zitieren
APA
Fang, Y., Huang, W., Zhu, X., Wang, X., Wu, X., Wang, H., Hong, W., Yan, S., Zhang, L., Deng, Y., Wei, W., Tu, J., & Zhu, C. (2024). Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis. Arthritis & Rheumatology, 76(6), 845-856. https://doi.org/10.1002/art.42795
Vancouver
Fang Y, Huang W, Zhu X, Wang X, Wu X, Wang H, et al. Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis. Arthritis & Rheumatology. 2024;76(6):845-856. doi:10.1002/art.42795
BibTeX
@article{Fang2024,
author = {Fang, Yilong and Huang, Wei and Zhu, Xiangling and Wang, Xinming and Wu, Xuming and Wang, Huihui and Hong, Wenming and Yan, Shangxue and Zhang, Lingling and Deng, Yujie and Wei, Wei and Tu, Jiajie and Zhu, Chen},
title = {Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis},
journal = {Arthritis & Rheumatology},
year = {2024},
volume = {76},
number = {6},
pages = {845--856},
doi = {10.1002/art.42795}
}
EUVIMED